Appointment booking for Dr. Michael Maehara, MD is currently not available.Dr. Michael Maehara, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Maehara, MD (he/him) is a Rheumatologist in Long Beach, CA with over 18 years of experience. What is your opinion of Dr. Michael Maehara, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Maehara, MD has received over $6,332 which includes payments from the following companies:
$2,469.57 from Pfizer Inc.
$2,252.80 from Celgene Corporation
$239.59 from sanofi-aventis U.S. LLC
$197.50 from Merck Sharp & Dohme Corporation
$192.93 from Janssen Pharmaceuticals, Inc
$150.99 from Sanofi Pasteur Inc.
$149.16 from Horizon Pharma plc
$103.04 from Gilead Sciences Inc
$100.00 from Fresenius Kabi USA, LLC
$96.79 from Boehringer Ingelheim Pharmaceuticals, Inc.
$77.99 from Amgen Inc.
$77.43 from LILLY USA, LLC
$73.66 from AbbVie, Inc.
$50.00 from AstraZeneca Pharmaceuticals LP
$20.07 from Radius Health, Inc.
$17.83 from Hologic, LLC
$14.84 from Mission Pharmacal Company
$13.19 from Novo Nordisk Inc
$12.38 from GlaxoSmithKline, LLC.
$11.63 from MEDAC PHARMA, INC.
Payments received by Dr. Michael Maehara, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!